Genocea Biosciences, Inc. - Product Pipeline Review - 2014 - Hawaii News Now - KGMB and KHNL

Genocea Biosciences, Inc. - Product Pipeline Review - 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer



 

 

 

LONDON, June 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Genocea Biosciences, Inc. - Product Pipeline Review - 2014

http://www.reportbuyer.com/pharma_healthcare/treatments/genocea_biosciences_inc_product_pipeline_review_2013.html

Genocea Biosciences, Inc. - Product Pipeline Review - 2014


Summary

Global Markets Direct's, 'Genocea Biosciences, Inc. - Product Pipeline Review - 2014', provides an overview of the Genocea Biosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Genocea Biosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Genocea Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Genocea Biosciences, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Genocea Biosciences, Inc.'s pipeline products

Reasons to buy

- Evaluate Genocea Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Genocea Biosciences, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Genocea Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Genocea Biosciences, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Genocea Biosciences, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Genocea Biosciences, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents

Genocea Biosciences, Inc. Snapshot 4
Genocea Biosciences, Inc. Overview 4
Key Information 4
Key Facts 4
Genocea Biosciences, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Genocea Biosciences, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Genocea Biosciences, Inc. - Pipeline Products Glance 9
Genocea Biosciences, Inc. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Genocea Biosciences, Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Genocea Biosciences, Inc. - Drug Profiles 11
GEN-003 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
GEN-004 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
GEN-001 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
GEN-002 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
GEN-005 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Gonorrhea Vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Genocea Biosciences, Inc. - Pipeline Analysis 18
Genocea Biosciences, Inc. - Pipeline Products by Route of Administration 18
Genocea Biosciences, Inc. - Pipeline Products by Molecule Type 19
Genocea Biosciences, Inc. - Recent Pipeline Updates 20
Genocea Biosciences, Inc. - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Tables

Genocea Biosciences, Inc., Key Information 4
Genocea Biosciences, Inc., Key Facts 4
Genocea Biosciences, Inc. - Pipeline by Indication, 2014 6
Genocea Biosciences, Inc. - Pipeline by Stage of Development, 2014 7
Genocea Biosciences, Inc. - Monotherapy Products in Pipeline, 2014 8
Genocea Biosciences, Inc. - Phase II, 2014 9
Genocea Biosciences, Inc. - Preclinical, 2014 10
Genocea Biosciences, Inc. - Pipeline by Route of Administration, 2014 18
Genocea Biosciences, Inc. - Pipeline by Molecule Type, 2014 19
Genocea Biosciences, Inc. - Recent Pipeline Updates, 2014 20

List of Figures

Genocea Biosciences, Inc. - Pipeline by Top 10 Indication, 2014 6
Genocea Biosciences, Inc. - Pipeline by Stage of Development, 2014 7
Genocea Biosciences, Inc. - Monotherapy Products in Pipeline, 2014 8
Genocea Biosciences, Inc. - Pipeline by Top 10 Molecule Type, 2014 19


Read the full report:
Genocea Biosciences, Inc. - Product Pipeline Review - 2014

http://www.reportbuyer.com/pharma_healthcare/treatments/genocea_biosciences_inc_product_pipeline_review_2013.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

©2012 PR Newswire. All Rights Reserved.